Eliem Therapeutics, Inc. (ELYM)
- Previous Close
7.36 - Open
7.37 - Bid 6.76 x 100
- Ask 7.28 x 100
- Day's Range
6.80 - 7.51 - 52 Week Range
2.35 - 11.55 - Volume
1,109,041 - Avg. Volume
222,103 - Market Cap (intraday)
468.751M - Beta (5Y Monthly) -0.32
- PE Ratio (TTM)
-- - EPS (TTM)
-2.22 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Eliem Therapeutics, Inc., a biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems. The company was incorporated in 2018 and is headquartered in Wilmington, Delaware.
eliemtx.comRecent News: ELYM
View MorePerformance Overview: ELYM
Trailing total returns as of 8/30/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ELYM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ELYM
View MoreValuation Measures
Market Cap
467.41M
Enterprise Value
244.37M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
2.10
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-24.54%
Return on Equity (ttm)
-38.35%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-64.19M
Diluted EPS (ttm)
-2.22
Balance Sheet and Cash Flow
Total Cash (mrq)
223.14M
Total Debt/Equity (mrq)
0.05%
Levered Free Cash Flow (ttm)
-29.91M